0000000000644635

AUTHOR

Giovanni Di Nardo

0000-0002-9026-7758

showing 2 related works from this author

The pediatric endoscopy practice in Italy: A nationwide survey on behalf of the Italian society of pediatric gastroenterology, hepatology and nutriti…

2019

medicine.medical_specialtyAdolescentEndoscopy Digestive System Pediatrics Gastroenterology ItalyMEDLINENutritional StatusNationwide surveyPediatricsNOInternal medicinemedicineHumansEndoscopy Digestive SystemChildPediatric gastroenterologySocieties Medicaldigestive endoscopyPediatric endoscopyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyInfant NewbornInfantNutritional statusEndoscopyHepatologyEndoscopyMulticenter studyItalypediatric endoscopy; digestive endoscopy; gastroenterologyFamily medicineChild PreschoolHealth Care SurveysPediatric endoscopybusinessDigestive System
researchProduct

Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group

2022

Objective: The aim was to assess the awareness and real-life use of biosimilars in inflammatory bowel disease (IBD) among the members of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP). Methods: An anonymous web survey involving all SIGENP IBD units which can prescribe biosimilars was conducted between July 1st and December 1st, 2020. The questionnaire included 18 questions addressing the most relevant aspects of biosimilars in pediatric IBD, i.e., advantages, disadvantages, costs, traceability, general knowledge, and real-life use. A descriptive analysis of responses was performed. Results: Responses came from 26 pediatric IBD units in Italy, with repre…

Inflammatory Bowel Diseasesbiosimilars; inflammatory bowel disease; childrendigestive system diseasesChild; Chronic Disease; Humans; Surveys and Questionnaires; Biosimilar Pharmaceuticals; Inflammatory Bowel DiseasesSurveys and QuestionnairesPediatrics Perinatology and Child HealthChronic DiseaseSurveys and QuestionnaireHumansPharmacology (medical)ChildBiosimilar PharmaceuticalsHumanBiosimilar Pharmaceutical
researchProduct